Johanneke E.A. Portielje

Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial

Annemieke Cats, Edwin P. M. Jansen, Nicole C.T. van Grieken et al. · The Lancet Oncology · 2018 · 562 citations

Surgical Oncology, Chemotherapy Versus Chemoradiotherapy, Gastrointestinal Oncology +8

Morbidity and mortality in adults with idiopathic thrombocytopenic purpura

Johanneke E.A. Portielje, Rudi G. J. Westendorp, Hanneke C. Kluin‐Nelemans et al. · Blood · 2001 · 494 citations · Full text

DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis

Linda M. Henricks, Carin A.T.C. Lunenburg, Femke M. de Man et al. · The Lancet Oncology · 2018 · 403 citations · Full text

Medicine, Prospective Safety Analysis, Cancer Management +9

Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial

Stefanie de Groot, Rieneke T. Lugtenberg, Danielle Cohen et al. · Nature Communications · 2020 · 320 citations · Full text

Frailty and malnutrition predictive of mortality risk in older patients with advanced colorectal cancer receiving chemotherapy

Ab A. Aaldriks, Lydia G. van der Geest, Erik J. Giltay et al. · Journal of Geriatric Oncology · 2013 · 242 citations

Geriatric Oncology, Aging, Geriatrics +11